Effect of development of health care system in emerging market countries to existing pharmaceutical industry

From ScenarioThinking
Revision as of 20:09, 16 September 2009 by Susan Liu (talk | contribs) (→‎Experts:)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

This page is under construction and edited by Susan Liu EMBA09. In case of any questions/remarks, feel free to contact me

Description:

Generic durgs will be mainstream. Western pharmaceutical companies no longer can hold on to their patent with current business model.

Enablers:

WHO

India medical development

Inhibitors:

Giant pharmaceutical corporations in emgerging markets

De-globalization

Paradigms:

Well being vs. Treating the sick

Experts:

WHO

Timing:

Dates for key milestones in the development of the driving force.

Web Resources:

Useful resources on the web relating to this force.

Retrieved from "https://www.scenariothinking.org/index.php?title=Effect_of_development_of_health_care_system_in_emerging_market_countries_to_existing_pharmaceutical_industry&oldid=28797"